Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways

Atherosclerosis

Volumn 210, Issue 1, 2010, Pages 71-77

  Jiang, Hailong ^a   Liang, Chun ^a   Liu, Xing ^a   Jiang, Qijun ^a   He, Zhiqing ^a   Wu, Jianxiang ^a   Pan, Xiaoming ^a   Ren, Yusheng ^a   Fan, Min ^a   Li, Mei ^a   Wu, Zonggui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Endothelial progenitor cells; Mitogen activated protein kinase; Palmitic acid

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; FATTY ACID; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PALMITIC ACID; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL STRUCTURE; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STEM CELL; UPREGULATION; WESTERN BLOTTING;

ANTHRACENES; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; ENDOTHELIAL CELLS; FLAVONOIDS; FLOW CYTOMETRY; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PALMITIC ACID; PYRIDINES; STEM CELLS; UP-REGULATION;

EID: 77952427744     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.032     Document Type: Article

References (45)

1. Castro Cabezas M., Erkelens D.W., van Dijk H. Free fatty acids: mediators of insulin resistance and atherosclerosis. Ned Tijdschr Geneeskd 2002, 146(3):103-109.
2. Smith S.R., Wilson P.W. Free fatty acids and atherosclerosis-guilty or innocent?. J Clin Endocrinol Metab 2006, 91(7):2506-2508.
3. Armstrong K.A., Hiremagalur B., Haluska B.A., et al. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation 2005, 80(7):937-944.
4. Perez F.R., Pineiro V., De La Cruz L.F., Casanueva F.F., Casabiell X. Vascular wall: potential target for the physicochemical effects of cis-unsaturated free fatty acids. Microsc Res Tech 2003, 60(1):23-29.
5. Stentz F.B., Kitabchi A.E. Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun 2006, 346(3):721-726.
6. Moers A., Schrezenmeir J. Palmitic acid but not stearic acid inhibits NO-production in endothelial cells. Exp Clin Endocrinol Diabetes 1997, 105(Suppl 2):78-80.
7. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111(22):2981-2987.
8. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600.
9. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-7.
10. Urbich C., Knau A., Fichtlscherer S., et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 2005, 19(8):974-976.
11. Srivastava D., Ivey K.N. Potential of stem-cell-based therapies for heart disease. Nature 2006, 441(7097):1097-1099.
12. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
13. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92(2):362-367.
14. Werner N., Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler Thromb Vasc Biol 2006, 26(2):257-266.
15. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333(9):550-554.
16. Muslin A.J. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond) 2008, 115(7):203-218.
17. Seeger F.H., Haendeler J., Walter D.H., et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005, 111(9):1184-1191.
18. Sun C., Liang C., Ren Y., et al. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 2009, 104(1):42-49.
19. Svedberg J., Bjorntorp P., Smith U., Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990, 39(5):570-574.
20. Caporali A., Pani E., Horrevoets A.J., et al. Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res 2008, 103(2):e15-26.
21. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995, 184(1):39-51.
22. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109(5):1801-1809.
23. Honda A., Matsuura K., Fukushima N., Tsurumi Y., Kasanuki H., Hagiwara N. Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway. Atherosclerosis 2009, 205(2):376-384.
24. Juliet P.A., Hayashi T., Iguchi A., Ignarro L.J. Concomitant production of nitric oxide and superoxide in human macrophages. Biochem Biophys Res Commun 2003, 310(2):367-370.
25. Kaur S., Kumar T.R., Uruno A., Sugawara A., Jayakumar K., Kartha C.C. Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study. Basic Res Cardiol 2009, 104(6):739-749.
26. Pistrosch F., Herbrig K., Oelschlaegel U., et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 2005, 183(1):163-167.
27. + cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006, 27(18):2247-2255.
28. +/CD45-progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. J Intern Med 2009.
29. Patil S., Sheng L., Masserang A., Chan C. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Neurosci Lett 2006, 406(1-2):55-59.
30. Dyntar D., Eppenberger-Eberhardt M., Maedler K., et al. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 2001, 50(9):2105-2113.
31. Guo W.X., Yang Q.D., Liu Y.H., Xie X.Y., Wang M., Niu R.C. Palmitic and linoleic acids impair endothelial progenitor cells by inhibition of Akt/eNOS pathway. Arch Med Res 2008, 39(4):434-442.
32. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824):37-40.
33. Dhanasekaran D.N., Reddy E.P. JNK signaling in apoptosis. Oncogene 2008, 27(48):6245-6251.
34. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005, 15(1):11-18.
35. Chai W., Liu Z. p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells. Endocrinology 2007, 148(4):1622-1628.
36. Cubbon R.M., Rajwani A., Wheatcroft S.B. The impact of insulin resistance on endothelial function, progenitor cells and repair. Diab Vasc Dis Res 2007, 4(2):103-111.
37. Tripathy D., Mohanty P., Dhindsa S., et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003, 52(12):2882-2887.
38. 2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006, 18(3):391-399.
39. Ma F.X., Zhou B., Chen Z., et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006, 47(6):1227-1237.
40. Zhao T.C., Taher M.M., Valerie K.C., Kukreja R.C. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS. Circ Res 2001, 89(10):915-922.
41. Jeon E.S., Lee M.J., Sung S.M., Kim J.H. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK. J Cell Biochem 2007, 100(6):1536-1547.
42. Zhang Y., Herbert B.S., Rajashekhar G., et al. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-{alpha} via the p38 mitogen-activated protein kinase pathway. FASEB J 2009.
43. Pirro M., Mauriege P., Tchernof A., et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 2002, 160(2):377-384.
44. Inouye M., Mio T., Sumino K. Dicarboxylic acids as markers of fatty acid peroxidation in diabetes. Atherosclerosis 2000, 148(1):197-202.
45. Haversen L., Danielsson K.N., Fogelstrand L., Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 2009, 202(2):382-393.